European Journal of Clinical Pharmacology

Top Research Topics at European Journal of Clinical Pharmacology?

The objective of European Journal of Clinical Pharmacology is to combine knowledge in the areas of Internal medicine, Pharmacology, Pharmacokinetics, Endocrinology and Anesthesia. The studies in Internal medicine featured incorporate elements of Gastroenterology, Surgery and Cardiology. The journal connects the study in Pharmacology with the closely related area of Crossover study.

While work presented in the journal provided substantial information on Pharmacokinetics, it also covered topics in Oral administration and Metabolite. Endocrinology studies presented in it focus on topics such as Excretion, Blood plasma and Metabolism. Topics in Anesthesia explored in European Journal of Clinical Pharmacology were investigated in conjunction with research in Placebo, Adverse effect, Chemotherapy and Blood pressure.

Studies on Blood pressure discussed in the journal link to the field of Hemodynamics. The Drug research presented in the journal explores the relationship between Medical prescription and the closely related topic of Pediatrics. It addresses concerns in Pharmacology toxicology which are intertwined with other disciplines, such as MEDLINE and Intensive care medicine.

• Internal medicine (38.34%)
• Pharmacology (34.11%)
• Pharmacokinetics (31.79%)

What are the most cited papers published in the journal?

• A Bayesian neural network method for adverse drug reaction signal generation (638 citations)
• Defective N-oxidation of sparteine in man: a new pharmacogenetic defect. (583 citations)
• Safety, pharmacodynamics, and pharmacokinetics of BAY 59-7939--an oral, direct Factor Xa inhibitor--after multiple dosing in healthy male subjects. (571 citations)

Research areas of the most cited articles at European Journal of Clinical Pharmacology:

The published papers primarily focus on research topics in Pharmacology, Pharmacokinetics, Internal medicine, Endocrinology and Anesthesia. In addition to Pharmacokinetics research, the journal papers aim to explore topics under Oral administration and Bioavailability. The published papers explore topics in Internal medicine which can be helpful for research in disciplines like Gastroenterology, Pharmacogenetics, Surgery and Cardiology.

What topics the last edition of the journal is best known for?

• Internal medicine
• Pharmacology
• Diabetes mellitus

The previous edition focused in particular on these issues:

European Journal of Clinical Pharmacology investigates studies in Internal medicine, Pharmacology toxicology, Pharmacokinetics, Adverse effect and Randomized controlled trial. While Internal medicine is the focus of it, it also provided insights into the studies of Gastroenterology and Oncology. The work tackled in it goes beyond the discipline of Gastroenterology as it also encompasses Genotype.

While European Journal of Clinical Pharmacology focused on Pharmacology toxicology, it was also able to explore topics like Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), Medical physics, MEDLINE and Intensive care medicine. The presentations focused mostly on Pharmacokinetics in an attempt to further explore topics in Pharmacology. Some problems in Randomized controlled trial that were presented in it overlapped with concepts under Placebo and Clinical trial.

The most cited articles from the last journal are:

• Therapeutic drug monitoring of oral targeted antineoplastic drugs. (19 citations)
• Tocilizumab for treating COVID-19: a systemic review and meta-analysis of retrospective studies. (14 citations)
• Pattern of treatment of behavioural and psychological symptoms of dementia and pain: evidence on pharmacoutilization from a large real-world sample and from a centre for cognitive disturbances and dementia. (11 citations)

Papers citation over time

A key indicator for each journal is its effectiveness in reaching other researchers with the papers published at that venue.

The chart below presents the interquartile range (first quartile 25%, median 50% and third quartile 75%) of the number of citations of articles over time.

Top authors and change over time

The top authors publishing in European Journal of Clinical Pharmacology (based on the number of publications) are:

• Arne Melander (57 papers) absent at the last edition,
• Jean-Louis Montastruc (56 papers) published 2 papers at the last edition, 2 less than at the previous edition,
• Pertti J. Neuvonen (52 papers) absent at the last edition,
• Kim Brøsen (44 papers) absent at the last edition,
• Leif Bertilsson (43 papers) absent at the last edition.

The overall trend for top authors publishing in this journal is outlined below. The chart shows the number of publications at each edition of the journal for top authors.

Top affiliations and change over time

Only papers with recognized affiliations are considered

The top affiliations publishing in European Journal of Clinical Pharmacology (based on the number of publications) are:

• Karolinska Institutet (301 papers) published 6 papers at the last edition, 3 less than at the previous edition,
• University of Helsinki (158 papers) published 2 papers at the last edition the same number as at the previous edition,
• French Institute of Health and Medical Research (140 papers) published 6 papers at the last edition, 2 more than at the previous edition,
• Novartis (118 papers) published 1 paper at the last edition,
• University of Oslo (115 papers) published 3 papers at the last edition, 1 less than at the previous edition.

The overall trend for top affiliations publishing in this journal is outlined below. The chart shows the number of publications at each edition of the journal for top affiliations.

Publication chance based on affiliation

The publication chance index shows the ratio of articles published by the best research institutions in the journal edition to all articles published within that journal. The best research institutions were selected based on the largest number of articles published during all editions of the journal.

The chart below presents the percentage ratio of articles from top institutions (based on their ranking of total papers).Top affiliations were grouped by their rank into the following tiers: top 1-10, top 11-20, top 21-50, and top 51+. Only articles with a recognized affiliation are considered.

During the most recent 2021 edition, 10.07% of publications had an unrecognized affiliation. Out of the publications with recognized affiliations, 9.96% were posted by at least one author from the top 10 institutions publishing in the journal. Another 7.47% included authors affiliated with research institutions from the top 11-20 affiliations. Institutions from the 21-50 range included 11.62% of all publications and 70.95% were from other institutions.

Returning Authors Index

A very common phenomenon observed among researchers publishing scientific articles is the intentional selection of journals they have already attended in the past. In particular, it is worth analyzing the case when the authors participate in the same journal from year to year.

The Returning Authors Index presented below illustrates the ratio of authors who participated in both a given as well as the previous edition of the journal in relation to all participants in a given year.

Returning Institution Index

The graph below shows the Returning Institution Index, illustrating the ratio of institutions that participated in both a given and the previous edition of the conference in relation to all affiliations present in a given year.

The experience to innovation index

Our experience to innovation index was created to show a cross-section of the experience level of authors publishing in a journal. The index includes the authors publishing at the last edition of a journal, grouped by total number of publications throughout their academic career (P) and the total number of citations of these publications ever received (C).

The group intervals were selected empirically to best show the diversity of the authors' experiences, their labels were selected as a convenience, not as judgment. The authors were divided into the following groups:

• Novice - P < 5 or C < 25 (the number of publications less than 5 or the number of citations less than 25),
• Competent - P < 10 or C < 100 (the number of publications less than 10 or the number of citations less than 100),
• Experienced - P < 25 or C < 625 (the number of publications less than 25 or the number of citations less than 625),
• Master - P < 50 or C < 2500 (the number of publications less than 50 or the number of citations less than 2500),
• Star - P ≥ 50 and C ≥ 2500 (both the number of publications greater than 50 and the number of citations greater than 2500).

The chart below illustrates experience levels of first authors in cases of publications with multiple authors.

Potential Careers in Clinical Pharmacology

While we've established that the European Journal of Clinical Pharmacology provides substantial insight into the most contemporary research within the fields of Internal Medicine, Pharmacology, Pharmacokinetics, and more, it is worth exploring the potential career paths that such a wealth of knowledge could be applied towards. A background in these areas could open doors to numerous rewarding professions within the health field.

For instance, some readers may be interested in venturing into the field of nursing, specifically, the role of a Nurse Practitioner. This highly-skilled, autonomous role blends clinical expertise in diagnosing and treating health conditions with an emphasis on disease prevention and health management. In Texas, for example, becoming a Nurse Practitioner requires specific educational criteria and licensure standards. For more information on pursuing this career path, you can read more about {how to become a nurse practitioner in Texas} here.

Beyond nursing, there are numerous careers that the knowledge decoded from the European Journal of Clinical Pharmacology could be used for. Careers in Pharmacology, Pharmaceutical Sciences, Pharmaceutical Manufacturing, Regulative authorities, Research and Development, Academia and many more. The Journal is a boon for those individuals who wish to further their careers in these areas, providing them with up-to-date research findings and relevant developments in the field.

Regardless of your specific career goal, engaging with cutting-edge research from sources such as the European Journal of Clinical Pharmacology is an excellent way to enhance your knowledge and skills. As you continue to read and learn, you will be better prepared to contribute to your chosen profession and make a significant impact in your field.